US 11576922
CD73 inhibitors
granted A61KA61K31/675A61K31/7064
Quick answer
US patent 11576922 (CD73 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K31/675, A61K31/7064, A61K45/06, A61P